• Increased Profits • Energy Control • Energy Management • Sustainable Operations P R O C E S S I N G EYE HEALTH International wellness company Lycored has announced it will continue its research programme into the effects of Lycoinvision - its nutrient complex for vision health - because of the success of a pre-clinical ex-vivo study. Emsol, Your Leading Energy Management Specialist Relevant expertise: • Food Processing • Process Heat • Carbon Reduction • Refrigeration • Cool Stores Since our establishment in 2002, we have been promoting the need to embed long-term energy management into processes and planning. Being a customer service driven consultancy, Emsol works with its clients to identify and satisfy their Energy Management needs. Emsol’s holistic approach to saving energy relates to the processes, education, and cultural changes within organisations. Emsol operates all over New Zealand Energy Management Solutions Limited | 151A Trafalgar St, Nelson | PO Box 3477 | Richmond 7050 | New Zealand P +64 03 546 6690 | M + 64 027 449 5288 | 30 FEBRUARY 2018 E erin.roughton@emsol.co.nz | W www.emsol.co.nz FT421 SAVE ENERGY, BOOST PROFITS Emsol works with some of the largest food processing businesses in New Zealand, and has extensive experience working with red meat, seafood, poultry and rendering products; as well as a strong familiarity with food processing technologies and operations. Working with a range of clients, Emsol has found that the combined effect of its expertise together with a business's strong commitment to energy savings results in the greatest savings. Many sites are saving energy costs between 10% and 40% annually, which increases profits. Energy performance monitoring is a key ingredient in achieving energy savings and some businesses find this to be the logical low-cost starting point. Other meat processing businesses find that during times of maintenance or equipment upgrades are key opportunities to work on energy savings projects, such as when upgrading old boilers or changing to heat recovery instead. The United States-based company, which funded the study by scientists from Hadassah-Hebrew University Medical Center in Israel, says the effect of Lycoinvision on immune cells from patients with age-related macular degeneration is exciting. The study has highlighted how adding the phytonutrient combination of tomato and rosemary to the already well-researched AREDS composition can better balance the cellular response to different challenges, and modulate specific biomarkers and key processes affecting eye health. “The exact role that lycopene plays in eye health has been a long-standing mystery, as lycopene does not accumulate in the eye,” Lycored’s Dr Karin Hermoni says. “This study allowed us to finally reveal the pivotal and synergistic role that it plays in vision protection. Research also suggests that Lycopene sacrifices itself for lutein by protecting it from oxidation - allowing lutein to be effectively transported to the eye. The current study emphasises that although lycopene does not contribute directly to macular pigmentation (like lutein does), it works in tandem with the other nutrients to help create the most potent combination of eye-protecting nutrients.” To arrive at their findings, Monocyte immune cells were separated from the blood of patients with AMD (both men and women) and matured to macrophages (polarisation to classic (M1) and alternative (M2) phenotypes). From there, each patient’s cells were treated with different combinations of nutrients, revealing the most potent combination to be the one containing lycopene and Carnosic acid in addition to the well-researched lutein/zeaxanthin and AREDS minerals zinc and copper. This combination was shown to boost overall natural protection mechanisms against different stresses and provide antioxidant protection. Lycored aims to use this ex-vivo eye health study as a way to support the innovation, importance and methodologies of such work…highlighting how a real-time pre-clinical study can be seen as the glue between a notion and a trusted, finished product, Hermoni says. “In its commitment to supporting eye health and continuing research in the field, the results from the ex-vivo study are just the beginning for Lycored, as the company continues the clinical portion (phase II) of the research programme, focusing on macular blood flow this year.” www.lycored.com
FT-eMag-feb18
To see the actual publication please follow the link above